These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29773501)

  • 1. What Is New in Neuromodulation for Overactive Bladder?
    Tutolo M; Ammirati E; Van der Aa F
    Eur Urol Focus; 2018 Jan; 4(1):49-53. PubMed ID: 29773501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of the percutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms].
    Kozma B; Majoros A; Pytel Á; Póka R; Takács P
    Orv Hetil; 2018 Oct; 159(43):1735-1740. PubMed ID: 30346235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature.
    Tutolo M; Ammirati E; Heesakkers J; Kessler TM; Peters KM; Rashid T; Sievert KD; Spinelli M; Novara G; Van der Aa F; De Ridder D
    Eur Urol; 2018 Mar; 73(3):406-418. PubMed ID: 29336927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuromodulation of lower urinary tract dysfunction].
    Kessler TM; de Wachter S
    Urologe A; 2017 Dec; 56(12):1591-1596. PubMed ID: 29063170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
    Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J
    Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic value of neuromodulation in women].
    van Ophoven A
    Urologie; 2023 Feb; 62(2):153-164. PubMed ID: 36690725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis.
    Lo CW; Wu MY; Yang SS; Jaw FS; Chang SJ
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review.
    Pericolini M; Miget G; Hentzen C; Finazzi Agrò E; Chesnel C; Lagnau P; Haddad R; Grasland M; Amarenco G
    Neuromodulation; 2022 Dec; 25(8):1065-1075. PubMed ID: 34496454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where Are We Headed with Neuromodulation for Overactive Bladder?
    Jaqua K; Powell CR
    Curr Urol Rep; 2017 Aug; 18(8):59. PubMed ID: 28656519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM; Eltabey NA; Wadie BS
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review.
    Levin PJ; Wu JM; Kawasaki A; Weidner AC; Amundsen CL
    Int Urogynecol J; 2012 Nov; 23(11):1591-7. PubMed ID: 22411208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.
    Rostaminia G; Chang C; Pincus JB; Sand PK; Goldberg RP
    Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?
    Tubaro A; Puccini F; De Nunzio C
    Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis.
    Zecca C; Panicari L; Disanto G; Maino P; Singh A; Digesu GA; Gobbi C
    Int Urogynecol J; 2016 Apr; 27(4):521-7. PubMed ID: 26245726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
    Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
    Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.